OBIO
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 40 | +9 | 9.68M | $41.77M | +13 | −4 |
| Q1 2026 | 31 | -5 | 6.77M | $28.77M | +3 | −8 |
| Q4 2025 | 36 | +3 | 6.47M | $26.85M | +3 | n/a |
| Q3 2025 | 12 | -1 | 3.92M | $9.71M | +1 | −2 |
| Q2 2025 | 10 | +3 | 3.39M | $9.08M | +3 | n/a |
| Q1 2025 | 4 | -1 | 1.55M | $6.63M | n/a | −1 |
| Q4 2024 | 5 | +1 | 1.54M | $6.17M | +1 | n/a |
| Q3 2024 | 3 | +1 | 1.10M | $5.66M | +1 | n/a |
| Q2 2024 | 2 | n/a | 1.11M | $9.04M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 556.22K | n/a | $4.53M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | T. Rowe Price ✦ | 552.70K | n/a | $4.51M | 0.0% | n/c | 1 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 64 holders, 23.09M shares, $97.96M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer, Director · See Remarks · 10.00K sh @ 4.79 · $47,900
Officer, Director · See Remarks · 2.00K sh @ 5.33 · $10,660
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology